These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35835989)

  • 1. Treatment of periocular lentigo maligna with topical 5% Imiquimod: a review.
    Neumann I; Patalay R; Kaushik M; Timlin H; Daniel C
    Eye (Lond); 2023 Feb; 37(3):408-414. PubMed ID: 35835989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lentigo maligna with imiquimod 5% cream.
    Hopson B; Richey D; Sajben FP
    J Drugs Dermatol; 2007 Oct; 6(10):1037-40. PubMed ID: 17966182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical imiquimod for periocular lentigo maligna.
    Demirci H; Shields CL; Bianciotto CG; Shields JA
    Ophthalmology; 2010 Dec; 117(12):2424-9. PubMed ID: 20591492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.
    Tio D; van der Woude J; Prinsen CAC; Jansma EP; Hoekzema R; van Montfrans C
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):616-624. PubMed ID: 27987308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
    Swetter SM; Chen FW; Kim DD; Egbert BM
    J Am Acad Dermatol; 2015 Jun; 72(6):1047-53. PubMed ID: 25791801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment.
    Tio DCKS; van Montfrans C; Ruijter CGH; Hoekzema R; Bekkenk MW
    Acta Derm Venereol; 2019 Sep; 99(10):884-888. PubMed ID: 31233181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
    Powell AM; Russell-Jones R
    J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lentigo maligna treated with 5% imiquimod cream].
    Martín T; Ojeda A; Martínez S; Vera A
    Actas Dermosifiliogr; 2005 Dec; 96(10):700-2. PubMed ID: 16476324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical imiquimod immunotherapy in the management of lentigo maligna.
    Powell AM; Russell-Jones R; Barlow RJ
    Clin Exp Dermatol; 2004 Jan; 29(1):15-21. PubMed ID: 14723712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imiquimod in the treatment of extensive recurrent lentigo maligna.
    Kamin A; Eigentler TK; Radny P; Bauer J; Weide B; Garbe C
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):51-2. PubMed ID: 15692515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences.
    Poveda-Montoyo I; Álvarez-Chinchilla P; Schneller-Pavelescu L; Hispán-Ocete P; Bañuls-Roca J
    Actas Dermosifiliogr; 2022 Apr; 113(4):T407-T412. PubMed ID: 35623739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences.
    Poveda-Montoyo I; Álvarez-Chinchilla P; Schneller-Pavelescu L; Hispán-Ocete P; Bañuls-Roca J
    Actas Dermosifiliogr; 2022 Apr; 113(4):407-412. PubMed ID: 35431054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod.
    Wolf IH; Cerroni L; Kodama K; Kerl H
    Arch Dermatol; 2005 Apr; 141(4):510-4. PubMed ID: 15837872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ.
    Bartenjev MS; Isaković-Vidović S; Bartenjev I
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):34-37. PubMed ID: 32650849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histologic features associated with lentigo maligna clearance after imiquimod treatment.
    Kwak R; Joyce C; Werchniak AE; Lin JY; Tsibris HC
    J Dermatolog Treat; 2022 Jun; 33(4):1995-1999. PubMed ID: 34315342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periocular lentigo maligna treated with imiquimod.
    O'Neill J; Ayers D; Kenealy J
    J Dermatolog Treat; 2011 Apr; 22(2):109-12. PubMed ID: 20666668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentigo maligna treated with topical imiquimod: dermatoscopy usefulness in clinical monitoring.
    Costa MC; Abraham LS; Barcaui C
    An Bras Dermatol; 2011; 86(4):792-4. PubMed ID: 21987152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
    Fleming CJ; Bryden AM; Evans A; Dawe RS; Ibbotson SH
    Br J Dermatol; 2004 Aug; 151(2):485-8. PubMed ID: 15327559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practical guide on the use of imiquimod cream to treat lentigo maligna.
    Guitera P; Waddell A; Paton E; Fogarty GB; Hong A; Scolyer RA; Stretch JR; O'Donnell BA; Pellacani G
    Australas J Dermatol; 2021 Nov; 62(4):478-485. PubMed ID: 34529272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod: a novel treatment for lentigo maligna.
    Ahmed I; Berth-Jones J
    Br J Dermatol; 2000 Oct; 143(4):843-5. PubMed ID: 11069469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.